To examine associations of systemic inflammation with growth outcomes at neonatal intensive care unit (NICU) discharge/transfer among infants with extremely low gestational ages. Source: PubMed Promoted on Twitter
“Our study is the first report to show molecular synergisms between bacteria, endosymbiont virus and protozoan parasite evading the human host – both with clinical association and experimental proof of causality,” said Raina Fichorova, MD, PhD, of the Brigham’s Department of…
Raina Fichorova, MD, PhD, of the Department of Obstetrics and Gynecology, received a Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for the development of Sage Gel, a biome-friendly vaginal moisturizer to relieve genitourinary menopausal…
Fairhaven Health has received a medical grant from a federally-funded agency for the development of Sage Gel, an isotonic biome-friendly vaginal moisturizer to relieve Genitourinary Menopausal Symptoms (GSM) for improved relief in postmenopausal women. The funding is part of the…
The Brigham Research Institute (BRI) announced the winners of the ninth “Shark Tank” competition, a biannual event featuring researchers and innovator from the Brigham who pitch their projects to an audience of internal reviewers and philanthropic supporters. Inspired by the…
As part of our commitment to training the next generation of health care professionals, each year BWH recruits underrepresented minority college and first-year medical students from around the U.S. for an eight-week mentored summer program known as the Summer Training…
Raina Fichorova, MD, PhD, was named the Walter Channing MD Distinguished Chair in Obstetrics and Gynecology at an October 28, 2016 ceremony. Fichorova, director of BWH's Laboratory of Genital Tract Biology, founded the laboratory in 2002. The laboratory's work has…
Raina Fichorova, MD, PhD, of the Department of Obstetrics and Gynecology, recently received an honorary master's degree from Harvard Medical School for her outstanding contributions to scientific research. The degree was presented by Jeffrey S. Flier, MD, dean of the…
A recent study may have found a biological explanation for why certain types of injectable and oral contraceptives can put women at increased risk of HIV infections. The study suggests these medications may suppress the vaginal immune response in certain…
Interactions between hormonal contraceptives and various genital tract infections may alter cervical immunity and increase the risk for HIV seroconversion among women, according to recently published data. “Before this study, there were all these controversial reports, some showing that [depot…